DailyBusiness.News

Daily Insights and news of Business, Industry and Market

Nexeon Raised £100m and Half of It Came From the State

Nexeon Raised £100m and Half of It Came From the State
The company is British, the technology is British, and the plant that makes the material at scale is in Gunsan. That gap is the whole story.

A British battery-materials company raised £100m at the end of August. A state investor provided £52.6m of it.

The National Wealth Fund’s commitment completed Nexeon’s latest round on 31 August, with Korea Development Bank and Honda Xcelerator Ventures also joining as new investors.

The proportion is the interesting part. A public body taking just over half of a growth round is not a passive co-investment; it is the round’s anchor, and it says something about who else was available to write that cheque.

What Silicon Anodes Actually Change

Nexeon makes silicon-based materials for the anode of a lithium-ion cell, the electrode that stores charge while the battery is full.

Conventional anodes use graphite. Silicon can hold considerably more lithium by weight, so replacing part of the graphite raises the energy density of the finished cell. In a car that shows up as two things a buyer notices: a shorter charge and a longer range from the same physical pack.

The reason it is not already universal is that silicon expands as it absorbs lithium, and the mechanical stress degrades the cell over repeated cycles. The engineering problem the whole sector has been working on is getting the density benefit without shortening the battery’s life, which is why materials firms in this space are valued on process know-how rather than on a product anyone can copy.

Dr Scott Brown, Nexeon’s chief executive, framed the round as validation of exactly that: “This investment is a strong endorsement of Nexeon’s technology and our role in enabling the next generation of lithium-ion batteries.”

A Pilot Plant, Not a Factory

The wording of what the money buys is precise and worth reading closely.

The financing supports a UK-based pilot manufacturing facility, expanded research and development, and the growth of Nexeon’s advanced manufacturing technology unit, alongside continued scale-up work towards high-volume manufacturing.

A pilot facility proves a process at a scale between the laboratory and the production line. It is where the recipe becomes repeatable, and it is genuinely necessary. It is not, however, a plant that ships commercial tonnage, and the announcement does not claim it is.

That distinction matters for anyone reading this as a jobs story. Highly skilled jobs are promised and will be real, but the headcount of a pilot line is measured in tens rather than the hundreds a volume plant employs.

The Volume Production Is in South Korea

The most revealing line in the announcement is about somewhere else entirely.

Nexeon recently launched what it describes as the first global volume production facility for silicon-carbon materials, in Gunsan, South Korea. The company is British, its technology is British, and the plant that makes the material at scale is not.

Set the two facts side by side and the shape of the deal becomes clear. Public money is funding the UK’s pilot capability while commercial volume is already established in a country with an existing battery manufacturing cluster, a domestic customer base of cell makers, and cheaper industrial power.

The presence of Korea Development Bank in the round reinforces the point rather than undercutting it. A Korean policy bank investing in a British company with a Korean plant is doing precisely what a national development bank exists to do, and it is competing for the same industrial capability the National Wealth Fund is trying to build here.

None of this makes the UK investment wrong. It does mean the honest test of it is not whether the pilot line gets built, but whether the volume plant that follows it is built here.

Read the Cap Table, Not the Press Release

Three new investors joined this round, and each is in it for a different reason. Taken together they describe the competition for this technology more clearly than any of the statements do.

Honda Xcelerator Ventures is the carmaker’s global open innovation arm, investing in mobility and electrification. A strategic investor of that kind is not primarily seeking a financial return; it is buying early sight of a material it may one day specify. That is the most genuinely bullish signal in the round, because a potential customer has looked at the technology closely and chosen to be inside it.

Korea Development Bank is a policy bank whose purpose includes supporting industrial innovation and the global expansion of Korean-linked manufacturing. Its presence is not a neutral endorsement. It is a national institution investing in a company that has just built its volume plant on Korean soil, which is exactly the outcome such a bank exists to secure.

The National Wealth Fund is the same instrument pointed the other way, trying to anchor capability in Britain. Two development banks from two countries are now shareholders in the same business, and they want different things from its next factory decision.

Nexeon’s chief financial officer, David Lamb, put the investor mix in the most favourable light available: “The quality of the Nexeon commercial proposition is reflected in the quality of investors we continue to attract.” That is fair, and it is also true that quality investors bring their own agendas.

For a company this is an enviable position. For UK industrial policy it is a reminder that owning equity is not the same as owning the decision, and that the other shareholder at the table has a mandate every bit as explicit as the Fund’s own.

Why a State Fund Took Half the Round

The Fund’s own reasoning is set out in a paper it recently co-published with the Clean Technology Partnership Initiative on the UK battery market.

Its conclusion is that two different instruments are needed: debt and guarantees for the very large supply-chain investments, and equity for scaling advanced technology firms. Nexeon sits squarely in the second category, and the size of the stake follows from the diagnosis rather than from enthusiasm.

Oliver Holbourn, the Fund’s chief executive, tied it to the mandate: “Our investment in Nexeon is fully aligned with our mission to support clean energy innovation and economic growth.” The deal is presented as meeting all three of the Fund’s strategic ambitions, including the strengthening of sovereign capability.

The uncomfortable implication is the one nobody states. If a materials company with proven technology, a Honda-backed cap table and a working plant abroad still needs a state investor to fill half a £100m round, private capital at that stage in this sector is thin. That is a diagnosis of the market, not of the company.

It Fits a Wider Pattern in UK Investment

The deal lands in a month when the direction of inbound industrial investment has been unmistakably downward.

Inbound energy projects into the UK fell to 27 while France took 50, with oil and gas down 81% and investors naming the cost of doing business as their third-ranked concern. Against that backdrop, a state fund anchoring a growth round looks less like industrial policy by preference and more like industrial policy by necessity.

The cost problem underneath it has not moved. British manufacturers pay some of the highest industrial electricity prices among their competitors, and in some sectors power costs exceed the producer’s entire value added. Battery materials processing is energy-intensive by nature, which is precisely the wrong characteristic to bring to a British electricity bill.

Equity from a state fund solves the capital problem for one company. It does not change the operating cost that will determine where the next plant goes.

What Would Count as Success

There is a clear and checkable test for this investment, and it is not the one the announcement invites.

Success is not the pilot line opening, which is nearly certain now the money is committed. It is not the technology working either, since Nexeon already has a volume plant proving that. It is whether, when the process is proven at pilot scale, the company chooses to build its next volume facility in the UK rather than extending Gunsan.

That decision will be made on industrial electricity prices, on proximity to cell manufacturers, on planning timelines and on whatever incentives exist at the time. A £52.6m equity stake gives the Fund a seat at the table for that conversation, which is a reasonable thing to have bought.

For anyone in the UK battery supply chain the practical read is to watch the pilot line’s output specification rather than its opening. If it is configured to feed British cell makers, the intent is genuine. If it is configured purely as a development facility, the commercial centre of gravity stays where the volume already is, and the sovereign capability being described remains a research capability rather than a manufacturing one.

About The Author